Biogen, maker of the Alzheimer's medicine Aduhelm, announced Wednesday that it would "discontinue the development and commercialization" of the controversial drug.
COVID-19's long-term effects on cognition in older adults will be studied for five years thanks to a $32 million federal grant awarded to The University of Texas Health Science Center at San Antonio (also called UT Health San Antonio).
Fat buried deep within the belly can increase the risk of developing Alzheimer’s disease, according to research released from the Radiological Society of North America (RSNA) on Monday.